Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients

NCT00429247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab

Sponsor

University Hospital of Crete